retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Retatrutide, a GIP, and receptor agonist, for people with type diabetes: a Retatrutide vs. Ozempic: The Triple
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6











:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)












